The incidence of cardiovascular events is largely reduced in hyper-Lp(a) patients on lipoprotein apheresis. The G.I.L.A. (gruppo interdisciplinare ldl aferesi) pilot study

Aim: Lipoprotein apheresis (LA) is the elective therapy for homozygous and other forms of Familial Hypercholesterolemia resistant/intolerant to lipid lowering drugs and hyperlipoproteinemia(a).

Source: Nutrition, Metabolism, and Cardiovascular Diseases : NMCD - December 31, 2016 Category: Nutrition Authors: F. Bigazzi, F. Sbrana, D. Berretti, M.G. Zenti, S. Zambon, A. Fabris, M. Fonda, G. D'Alessandri, B. Dal Pino, M. Pianelli, R. Luciani, A. Ripoli, D. Rafanelli, A. Colpo, L. Cattin, T. Sampietro Source Type: research